Baidu
map

Cell Metab:糖尿病患者不依赖胰岛素成为可能

2013-09-05 睿医编译 睿医资讯

日内瓦大学的研究者已经发现一种作用机制,这种作用机制对于糖尿病患者不依赖胰岛素生活至关重要,这项研究为糖尿病的新治疗方法铺平道路。全世界数百万人胰岛素分泌不足。胰岛素是一种由胰腺中的胰岛β细胞分泌的激素,其对诸如血糖等能量基质的控制至关重要。由糖尿病(1型和2型)导致的胰岛素分泌不足,如果不接受治疗,后果不堪设想。目前,患者只能通过每日注射胰岛素维持生命。但是这种方法伴随着严重的副作用。来日内瓦大

日内瓦大学的研究者已经发现一种作用机制,这种作用机制对于糖尿病患者不依赖胰岛素生活至关重要,这项研究为糖尿病的新治疗方法铺平道路。

全世界数百万人胰岛素分泌不足。胰岛素是一种由胰腺中的胰岛β细胞分泌的激素,其对诸如血糖等能量基质的控制至关重要。由糖尿病(1型和2型)导致的胰岛素分泌不足,如果不接受治疗,后果不堪设想。目前,患者只能通过每日注射胰岛素维持生命。但是这种方法伴随着严重的副作用。来日内瓦大学的研究者发现了可能的作用机制,证明了不依赖胰岛素可以生活,并为新的胰岛素治疗方法铺平了道路,这项研究刊登在《Cell Metabolism》杂志上。【原文下载】

尽管不依赖胰岛素生活听起来不可思议,研究者证明了胰岛素对维持生命来说并非至关重要。为了打翻传统理论并消除胰岛素治疗对患者造成的诸多风险,科学家正在研究胰岛素治疗的替代方案。一次剂量的错误即可能引起低血糖症(血管血糖水平下降,可能引起意识丧失)。此外,在超过55岁的患者中,有大约90%接受数十年胰岛素治疗的患者引发冠心病,这是由于胰岛素具有生成脂肪的属性,这种导致胆固醇水平升高。

瘦素引发了一个重要的发现。

来自日内瓦大学的研究者对缺乏胰岛素的啮齿类动物进行试验,他们使用瘦素(一种控制机体脂肪储存和食欲的激素)后,所有的试验对象均得以存活。瘦素的使用提供了两种好处:不会引起低血糖症并对脂肪分解有一定作用。通过这项研究,胰岛素治疗方案的替代方案脱颖而出。现在我们需要理解瘦素影响血糖水平的作用机制而非胰岛素水平。

原文下载

Teppei Fujikawa, Eric D. Berglund, Vishal R. Patel, Giorgio Ramadori, Claudia R. Vianna, Linh Vong, Fabrizio Thorel, Simona Chera, Pedro L. Herrera, Bradford B. Lowell, Joel K. Elmquist, Pierre Baldi, Roberto Coppari.Leptin Engages a Hypothalamic Neurocircuitry to Permit Survival in the Absence of Insulin.Cell Metabolism 18(3) pp. 431 - 444.


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1958916, encodeId=ee8f195891620, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Sun Jan 05 08:20:00 CST 2014, time=2014-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1868678, encodeId=7ec618686e866, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Wed Apr 09 00:20:00 CST 2014, time=2014-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1749434, encodeId=a65d1e494345e, content=<a href='/topic/show?id=be7c8385345' target=_blank style='color:#2F92EE;'>#胰岛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83853, encryptionId=be7c8385345, topicName=胰岛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7a536274692, createdName=baoya, createdTime=Mon Nov 18 18:20:00 CST 2013, time=2013-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1887357, encodeId=012d188e357e8, content=<a href='/topic/show?id=d56611584ec' target=_blank style='color:#2F92EE;'>#Meta#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11584, encryptionId=d56611584ec, topicName=Meta)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8f4110, createdName=guojianrong, createdTime=Fri Jul 18 03:20:00 CST 2014, time=2014-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1895678, encodeId=0c5c18956e8e9, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sun Oct 06 10:20:00 CST 2013, time=2013-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6121, encodeId=4bcb612102, content=真的可以么?, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Sep 09 15:10:00 CST 2013, time=2013-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473739, encodeId=9c1114e3739dc, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Sat Sep 07 00:20:00 CST 2013, time=2013-09-07, status=1, ipAttribution=)]
    2014-01-05 维他命
  2. [GetPortalCommentsPageByObjectIdResponse(id=1958916, encodeId=ee8f195891620, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Sun Jan 05 08:20:00 CST 2014, time=2014-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1868678, encodeId=7ec618686e866, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Wed Apr 09 00:20:00 CST 2014, time=2014-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1749434, encodeId=a65d1e494345e, content=<a href='/topic/show?id=be7c8385345' target=_blank style='color:#2F92EE;'>#胰岛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83853, encryptionId=be7c8385345, topicName=胰岛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7a536274692, createdName=baoya, createdTime=Mon Nov 18 18:20:00 CST 2013, time=2013-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1887357, encodeId=012d188e357e8, content=<a href='/topic/show?id=d56611584ec' target=_blank style='color:#2F92EE;'>#Meta#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11584, encryptionId=d56611584ec, topicName=Meta)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8f4110, createdName=guojianrong, createdTime=Fri Jul 18 03:20:00 CST 2014, time=2014-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1895678, encodeId=0c5c18956e8e9, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sun Oct 06 10:20:00 CST 2013, time=2013-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6121, encodeId=4bcb612102, content=真的可以么?, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Sep 09 15:10:00 CST 2013, time=2013-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473739, encodeId=9c1114e3739dc, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Sat Sep 07 00:20:00 CST 2013, time=2013-09-07, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1958916, encodeId=ee8f195891620, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Sun Jan 05 08:20:00 CST 2014, time=2014-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1868678, encodeId=7ec618686e866, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Wed Apr 09 00:20:00 CST 2014, time=2014-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1749434, encodeId=a65d1e494345e, content=<a href='/topic/show?id=be7c8385345' target=_blank style='color:#2F92EE;'>#胰岛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83853, encryptionId=be7c8385345, topicName=胰岛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7a536274692, createdName=baoya, createdTime=Mon Nov 18 18:20:00 CST 2013, time=2013-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1887357, encodeId=012d188e357e8, content=<a href='/topic/show?id=d56611584ec' target=_blank style='color:#2F92EE;'>#Meta#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11584, encryptionId=d56611584ec, topicName=Meta)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8f4110, createdName=guojianrong, createdTime=Fri Jul 18 03:20:00 CST 2014, time=2014-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1895678, encodeId=0c5c18956e8e9, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sun Oct 06 10:20:00 CST 2013, time=2013-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6121, encodeId=4bcb612102, content=真的可以么?, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Sep 09 15:10:00 CST 2013, time=2013-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473739, encodeId=9c1114e3739dc, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Sat Sep 07 00:20:00 CST 2013, time=2013-09-07, status=1, ipAttribution=)]
    2013-11-18 baoya
  4. [GetPortalCommentsPageByObjectIdResponse(id=1958916, encodeId=ee8f195891620, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Sun Jan 05 08:20:00 CST 2014, time=2014-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1868678, encodeId=7ec618686e866, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Wed Apr 09 00:20:00 CST 2014, time=2014-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1749434, encodeId=a65d1e494345e, content=<a href='/topic/show?id=be7c8385345' target=_blank style='color:#2F92EE;'>#胰岛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83853, encryptionId=be7c8385345, topicName=胰岛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7a536274692, createdName=baoya, createdTime=Mon Nov 18 18:20:00 CST 2013, time=2013-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1887357, encodeId=012d188e357e8, content=<a href='/topic/show?id=d56611584ec' target=_blank style='color:#2F92EE;'>#Meta#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11584, encryptionId=d56611584ec, topicName=Meta)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8f4110, createdName=guojianrong, createdTime=Fri Jul 18 03:20:00 CST 2014, time=2014-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1895678, encodeId=0c5c18956e8e9, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sun Oct 06 10:20:00 CST 2013, time=2013-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6121, encodeId=4bcb612102, content=真的可以么?, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Sep 09 15:10:00 CST 2013, time=2013-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473739, encodeId=9c1114e3739dc, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Sat Sep 07 00:20:00 CST 2013, time=2013-09-07, status=1, ipAttribution=)]
    2014-07-18 guojianrong
  5. [GetPortalCommentsPageByObjectIdResponse(id=1958916, encodeId=ee8f195891620, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Sun Jan 05 08:20:00 CST 2014, time=2014-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1868678, encodeId=7ec618686e866, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Wed Apr 09 00:20:00 CST 2014, time=2014-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1749434, encodeId=a65d1e494345e, content=<a href='/topic/show?id=be7c8385345' target=_blank style='color:#2F92EE;'>#胰岛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83853, encryptionId=be7c8385345, topicName=胰岛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7a536274692, createdName=baoya, createdTime=Mon Nov 18 18:20:00 CST 2013, time=2013-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1887357, encodeId=012d188e357e8, content=<a href='/topic/show?id=d56611584ec' target=_blank style='color:#2F92EE;'>#Meta#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11584, encryptionId=d56611584ec, topicName=Meta)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8f4110, createdName=guojianrong, createdTime=Fri Jul 18 03:20:00 CST 2014, time=2014-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1895678, encodeId=0c5c18956e8e9, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sun Oct 06 10:20:00 CST 2013, time=2013-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6121, encodeId=4bcb612102, content=真的可以么?, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Sep 09 15:10:00 CST 2013, time=2013-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473739, encodeId=9c1114e3739dc, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Sat Sep 07 00:20:00 CST 2013, time=2013-09-07, status=1, ipAttribution=)]
    2013-10-06 一闲
  6. [GetPortalCommentsPageByObjectIdResponse(id=1958916, encodeId=ee8f195891620, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Sun Jan 05 08:20:00 CST 2014, time=2014-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1868678, encodeId=7ec618686e866, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Wed Apr 09 00:20:00 CST 2014, time=2014-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1749434, encodeId=a65d1e494345e, content=<a href='/topic/show?id=be7c8385345' target=_blank style='color:#2F92EE;'>#胰岛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83853, encryptionId=be7c8385345, topicName=胰岛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7a536274692, createdName=baoya, createdTime=Mon Nov 18 18:20:00 CST 2013, time=2013-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1887357, encodeId=012d188e357e8, content=<a href='/topic/show?id=d56611584ec' target=_blank style='color:#2F92EE;'>#Meta#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11584, encryptionId=d56611584ec, topicName=Meta)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8f4110, createdName=guojianrong, createdTime=Fri Jul 18 03:20:00 CST 2014, time=2014-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1895678, encodeId=0c5c18956e8e9, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sun Oct 06 10:20:00 CST 2013, time=2013-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6121, encodeId=4bcb612102, content=真的可以么?, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Sep 09 15:10:00 CST 2013, time=2013-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473739, encodeId=9c1114e3739dc, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Sat Sep 07 00:20:00 CST 2013, time=2013-09-07, status=1, ipAttribution=)]
    2013-09-09 匿名用户

    真的可以么?

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1958916, encodeId=ee8f195891620, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Sun Jan 05 08:20:00 CST 2014, time=2014-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1868678, encodeId=7ec618686e866, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Wed Apr 09 00:20:00 CST 2014, time=2014-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1749434, encodeId=a65d1e494345e, content=<a href='/topic/show?id=be7c8385345' target=_blank style='color:#2F92EE;'>#胰岛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83853, encryptionId=be7c8385345, topicName=胰岛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7a536274692, createdName=baoya, createdTime=Mon Nov 18 18:20:00 CST 2013, time=2013-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1887357, encodeId=012d188e357e8, content=<a href='/topic/show?id=d56611584ec' target=_blank style='color:#2F92EE;'>#Meta#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11584, encryptionId=d56611584ec, topicName=Meta)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8f4110, createdName=guojianrong, createdTime=Fri Jul 18 03:20:00 CST 2014, time=2014-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1895678, encodeId=0c5c18956e8e9, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sun Oct 06 10:20:00 CST 2013, time=2013-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6121, encodeId=4bcb612102, content=真的可以么?, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Sep 09 15:10:00 CST 2013, time=2013-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473739, encodeId=9c1114e3739dc, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Sat Sep 07 00:20:00 CST 2013, time=2013-09-07, status=1, ipAttribution=)]

相关资讯

Pediatrics:塑料化学品或增儿童患肥胖和糖尿病风险

美国的研究人员近期开展了两项研究:邻苯二甲酸(一种化学品,平日用于制造香水,也可用于软化塑料的化学品)和双酚A(BPA,在工业上双酚A被用来合成聚碳酸酯和环氧树脂等材料,60年代以来就被用于制造塑料瓶、幼儿用的吸口杯、食品和饮料罐内侧涂层)与儿童胰岛素抵抗和肥胖之间的关系。

Int J Cardiol:大幅降压不改善2型糖尿病患者心血管疾病风险

ACCORD 研究表明,较低的血压水平没有益处。针对这一现象,开滦医院的吴寿岭等研究人员进行了一项大型队列研究,探究收缩压(SBP)与心血管事件风险的关系,结果发现将SBP降至130mm Hg以下并不改善糖尿病患者心血管事件风险,研究发表于《国际心脏病学杂志》。研究人员对2006年6月至2007年10月的研究数据进行了分析,本次研究共招募101,510名成人,招募人群空腹血糖水平高于7.0mmol

JAMA:中国成年人糖尿病发病率情况

糖尿病是以血糖升高为特征, 由胰岛素分泌缺乏或功能障碍导致糖代谢紊乱引起的代谢性疾病。目前世界上成人糖尿病患者约3.46 亿, 预计2030年,糖尿病发病人数将达到40亿。我国糖尿病发病自2000年以来,进入了快速增长期,如今,每天都有约16000人成为糖尿病患者,有约3000人死于由糖尿病引起的各种并发症。【原文下载】 近期来自上海交通大学医学院等处的研究

J Gastroenterol Hepatol:糖尿病患者消化性溃疡出血风险增加

据报道糖尿病患者有较高的消化性溃疡发病率。为了探讨2型糖尿病患者是否有较高的风险发生消化性溃疡出血(PUB),并确定糖尿病患者PUB可能的危险因素,来自台湾台北荣民总医院Yen-Ling Peng教授及其团队进行了一项研究,该研究发现2型糖尿病患者PUB风险显著升高。

AADE草案:减重是预防糖尿病前期进展的主要干预措施

根据美国糖尿病教育者协会(AADE)年会上公布的美国营养与饮食学会(AND)工作组建议草案,减轻体重是预防糖尿病前期进展至2型糖尿病的主要生活方式干预措施,但其他饮食干预措施也有帮助。

母义明:干细胞治疗糖尿病的现状与未来

  2013年8月22日--24日,第十二次全国内分泌学学术会议在西安隆重召开。在8月24日上午的大会报告上,解放军总医院内分泌科的母义明 教授进行了《干细胞治疗糖尿病的现状与未来》的报告。母义明教授阐述了各类干细胞在糖尿病治疗中的作用,通过一系列大型基础和临床研究结果介绍了干细胞治 疗糖尿病的疗效和可能的作用机制,并指出了未来可以进一步研究的方向。    

Baidu
map
Baidu
map
Baidu
map